China minimally invasive surgical (MIS) instruments market is expected to grow at a CAGR of around 8.9% during the forecast period. Minimally invasive surgical instruments market in China has significant potential growth owing to the technological innovations in MIS instruments. For instance, Tianjin University (China) has developed a minimally invasive robotic system, Micro Hand S which has successfully performed clinical surgery in 2015. The surgeries were performed at the Third Xiangya Hospital of Central South University for gastric perforation repair and an appendectomy.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/china-minimally-invasive-surgical-instruments-market
According to the University, there are three ways that make Micro Hand S superior to other foreign surgical robots. Firstly, it has finer and highly independent cable transmission, which is capable of being slip-resistant and fixed. This enables to offer a better longer life and precision. Secondly, the sensitivity and position of the robot can be adjusted according to the requirement of doctors. Thirdly, they have utilized a different kind of isomorphic control modeling technology that enables highly precise hand-eye – instrument motion consistency in a 3D visual environment. Moreover, the mechanical arm of the robot can swing and rotate freely within 360 degrees that enables to perform the more detailed and accurate procedure.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/china-minimally-invasive-surgical-instruments-market
The camera lens utilized inside of the human body is highly detailed compared to any human eye that provides ten times more precision and detail. In addition, the breakthrough 3D imaging technology enables to make the surgery location more accurate. The doctors can gain patient’s data at any time with virtual haptic feedback sensitivity technology and adjust the robotic scheme to meet their requirements. The doctor can finish the surgery by computer remote control and without the support of multiple doctors. Such kinds of innovations demonstrate the country’s focus toward robotic-assisted surgeries. As a result, technological innovations are expected to play a vital role to expand the opportunity for robotic-assisted surgeries in the country.
The major players in the market include Abbott Laboratories, Inc., Stryker Corp., Johnson & Johnson Services, Inc., and Medtronic plc. These companies are adopting several strategies to expand market share and gain a competitive advantage over their competitors. For instance, in July 2018, Terumo Corporation entered into an agreement to acquire Essen Technology (Beijing) Co., Ltd., a Chinese medical device company. Essen is a manufacturer of drug-eluting stents and the acquisition will enable Terumo to expand its interventional systems business in China.
Market Segmentation
China Minimally Invasive Surgical Instruments Market by Product
- Inflation Systems
- Cutter Instruments
- Guiding Devices
- Handheld Instruments
- Stents
- Sutures
- Monitoring and Visualization Equipment
- Robotic Assisted Surgical Systems
China Minimally Invasive Surgical Instruments Market by Technology
- Endoscopy
- Laparoscopy
- Robot-Assisted Methods
- Arthroscopic Techniques
- Ablative Methods
China Minimally Invasive Surgical Instruments Market by Application
- Cardiac Surgery
- Colorectal Surgery
- Dermatological Surgery
- ENT Surgery
- Gastrointestinal Surgery
- Gynecological Surgery
- Lung & Respiratory Care
- Neurosurgery
- Ophthalmology
- Orthopedics
- Others
Company Profiles
- Abbott Laboratories, Inc.
- Boston Scientific Corp.
- Edwards Lifesciences Corp.
- Johnson & Johnson Services, Inc.
- Koninklijke Philips N.V.
- Medtronic plc
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Stryker Corp.
- Teleflex, Inc.
- Terumo Medical Corp.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
